Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 May;17(5):377-81.
doi: 10.1046/j.1525-1497.2002.10644.x.

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

Julia H Arnsten  1 , Penelope A Demas, Richard W Grant, Marc N Gourevitch, Homayoon Farzadegan, Andrea A Howard, Ellie E Schoenbaum
Affiliations

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

Julia H Arnsten et al. J Gen Intern Med. 2002 May.

Abstract

Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27%, compared to 68% among subjects who reported no cocaine use during the 6-month study period. Consequently, 13% of active cocaine users maintained viral suppression, compared to 46% of nonusers. Interventions to improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2000;12(2)
    1. Celentano DD, Galai N, Sethi AK, et al. Time to initiating antiretroviral therapy among HIV-infected drug users. AIDS. 2001;15:1707–15. - PubMed
    1. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV cost and services utilization study. JAMA. 1999;281:2305–15. - PubMed
    1. Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280:547–9. - PubMed
    1. Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV infection. J Acquir Immune Defic Syndr. 2001;27:251–9. - PubMed

Publication types